Invention Grant
- Patent Title: Human cytomegalovirus neutralising antibodies and use thereof
-
Application No.: US13619305Application Date: 2012-09-14
-
Publication No.: US08545848B2Publication Date: 2013-10-01
- Inventor: Antonia Lanzavecchia , Annalisa Macagno
- Applicant: Antonia Lanzavecchia , Annalisa Macagno
- Applicant Address: CH Bellinzona
- Assignee: Institute for Research in Biomedicine
- Current Assignee: Institute for Research in Biomedicine
- Current Assignee Address: CH Bellinzona
- Agency: Nelson Mullins Riley & Scarborough LLP
- Agent Jane E. Remillard, Esq.; Jeanne M. DiGiorgio
- Priority: GB0700133.2 20070104
- Main IPC: A61K39/42
- IPC: A61K39/42 ; A61K39/395
Abstract:
The invention relates to neutralizing antibodies which are specific for human cytomegalovirus and bind with high affinity as well as immortalized B cells that produce such antibodies. The invention also relates to the epitopes that the antibodies bind to as well as the use of the antibodies and the epitopes in screening methods as well as the diagnosis and therapy of disease.
Public/Granted literature
- US20130101604A1 HUMAN CYTOMEGALOVIRUS NEUTRALISING ANTIBODIES AND USE THEREOF Public/Granted day:2013-04-25
Information query
